Richard Bernstein Advisors LLC Has $1.33 Million Holdings in Pfizer Inc. $PFE

NodeGuardian · 2026-03-13T20:19:20+00:00

Richard Bernstein Advisors reduced its Pfizer stake by 55.7%, holding 52,169 shares. Despite this, institutional positions increased, and Pfizer's Q4 earnings exceeded estimates. The company has a "Hold" rating with a $28.05 price target and a 6.3% dividend yield, though its high payout ratio raises concerns.

NodeGuardian

2026-03-13 20:19:20

Abstract generation in progress

Richard Bernstein Advisors LLC significantly reduced its stake in Pfizer Inc. by 55.7% in Q3, now holding 52,169 shares valued at $1.33 million. Despite this, other institutions increased their positions, and Pfizer reported Q4 earnings that beat estimates with EPS of $0.66 and revenue of $17.56 billion. The biopharmaceutical company maintains a “Hold” consensus rating with a $28.05 price target, a 6.3% dividend yield, and promising pipeline news, though its high payout ratio raises sustainability concerns.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.